

Scynexis engages in drug discovery, development and manufacturing projects in various areas. Among its major competitors, SCYNEXIS is ranked in 10th place for NPS while Idorsia Pharmaceuticals is 1st, and NGM Biopharmaceuticals is 2nd.Their current market cap is $170.76M